Here are three points:
1. The grants total $155,000.
2. The funds will help Bacterin International, a Xtant wholly-owned subsidiary, expand its orthobiologic process facility.
3. The grants will specifically contribute to new processing equipment, new job creation and job training.
More articles on devices:
Spinal Elements hits 50 US patents — 5 things to know
RBC Capital increases Stryker price target to $120 — 5 key facts
21 spine devices receive FDA 510(k) clearance in March
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
